Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer

Fig. 1

Expression of MIR31HG in BLCA tissue samples and cell lines. a In the TCGA cohort data, MIR31HG was down-regulated (median expression 0.2435) in tumors compared with normal tissues (median expression 0.3549). b In the TCGA cohort, expression of MIR31HG was higher in basal/squamous (median expression 7.10 with range of 0 to 9.96) subtype compared to luminal (median expression 3.16 with range of 0.13 to 6.8), luminal-infiltrated (median expression 4.99 with range of 0 to 9.16), luminal-papillary (median expression 5.53 with range of 0 to 9.92), and neuronal (median expression 4.92 with range of 0 to 8.7) subtypes. c In a normal urothelial cell line (UROtsa) and five BLCA cell lines (SCaBER, UMUC3, T24, RT112 and RT4), expression of MIR31HG was detected by qPCR. MIR31HG expression was significantly lower in UMUC3 and T24 cells, and higher in SCaBER cells compared to UROtsa cells. The lowest MIR31HG expression was observed in RT112 and RT4 cells

Back to article page